| Subject: | FDA Notice regarding Diazepam Rectal Gel |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Fri, 31 Mar 2006 - 10:00 am |
| Audience: Neurologists, pharmacists and consumers
Valeant Pharmaceuticals International and FDA have notified healthcare professionals of complaints the company received concerning small cracks at the base of the plastic tip of the applicators of Diastat AcuDial (diazepam rectal gel) with resulting leakage of the medication when the plunger is depressed, preventing full dosing and potentially resulting in a sub-optimal therapeutic response. There is also a risk of skin getting caught in any... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
External Links:
|
|
StayAlert! provides immediate online healthcare compliance validation to our healthcare users. When faced with dramatic reductions in healthcare dollars, StayAlert! focuses on those processes that can save the most time and money. By automating labor-intensive activities, StayAlert! almost instantly produces a positive impact on the healthcare user's bottom line. The policies alone included with the StayAlert! notices can save you $65,000 or more in labor costs each year. Organizations will realize dramatic cost savings through elimination of labor intensity, increased productivity with the benefit of ensuring regulatory compliance. StayAlert! is the service-oriented supplier of health care's compliance needs. Currently StayAlert! is the leader in the comprehensive compliance information marketplace. Why? Because StayAlert! provides healthcare professionals with more than information. StayAlert! provides a service, in many cases "doing the work" for you, and assisting regulatory compliance officers to effectively and efficiently meet changing standards. |
|
